Baxdrostat report suggests blood pressure benefits may outlast treatment
Reports describe benefits lasting up to two years after treatment in a small, selected group, not proof that baxdrostat can permanently cure high blood pressure.
The Guardian reports that some patients’ blood pressure stayed lower for up to two years after they stopped taking baxdrostat. The i and Mirror describe a follow-up involving 14 patients who had already responded strongly during an initial trial and then continued treatment. The reports raise the possibility of a lasting effect on a hormonal cause of high blood pressure, but the supplied excerpts do not establish a permanent cure.
What holds up
- ✓The Guardian, the i and Mirror describe lasting benefits after treatment. The i and Mirror agree that the follow-up involved 14 patients selected after substantial initial improvements, an important limit on how widely the results apply.
- ✓Separate background evidence supports blood pressure lowering during treatment: a July trial abstract indexed by PubMed reports a 14 mm Hg greater reduction in average 24-hour systolic pressure with baxdrostat than placebo at 12 weeks. That does not establish benefits after stopping.
What doesn't yet
- ?The i suggests baxdrostat could kill hormone-producing tumor cells and have permanent effects; the Guardian and Mirror also use cure language. The excerpts provide no direct evidence of cell destruction, and follow-up lasting up to two years cannot establish permanence.
- ?The excerpts do not show how many patients reached two years of follow-up, whether there was a comparison group after stopping, or how other medications changed. Mirror reports that just under a quarter stopped all blood pressure treatment, so stopping baxdrostat should not be confused with stopping every medication.
- ?Only a few outside newsrooms provide relevant coverage of the lasting-effect finding, and other accounts may be missing. UA News explicitly repeats the Guardian; multiple retellings of the same study are not separate clinical confirmation. These snippets are not full-article or study verification.
Ask before you share
- →How many of the 14 patients maintained lower blood pressure for the full two years, and what other treatments were they taking?
- →Did researchers compare these selected strong responders with similar patients who stopped treatment, and did they directly measure changes in hormone-producing cells?
- →Which patients could benefit, and will a larger study confirm lasting effects and assess safety?
Sources & original reporting
- [1]The Guardian · Published 8 Nov 2026 · theguardian.com
- [2]Inews · Published 7 Nov 2026 · inews.co.uk
- [3]Mirror · Published 8 Nov 2026 · mirror.co.uk
- [4]Ua · Published 8 Nov 2026 · ua.news
- [5]Pubmed Ncbi Nlm Nih · Published 3 Jul 2026 · pubmed.ncbi.nlm.nih.gov